New heart trial aims to improve rhythm control for persistent AF patients

NCT ID NCT07106970

Recruiting now Disease control Sponsor: Boston Scientific Corporation Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 30 times

Summary

This study compares two heart procedures for people with persistent atrial fibrillation (a type of irregular heartbeat). One group gets the standard treatment (pulmonary vein isolation) plus an extra step (linear ablation), while the other gets standard treatment alone. The goal is to see which approach better keeps the heart in normal rhythm without needing more procedures or long-term medication. About 640 adults aged 18 to 80 with symptomatic, drug-resistant persistent AF will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERSISTENT ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Beijing Anzhen Hospital, affiliated to Capital Medical University
RECRUITING

Beijing, 101118, China

Contact

Conditions

Explore the condition pages connected to this study.

PERSISTENT ATRIAL FIBRILLATION